Novartis and its partners invested heavily in expanding production capacity at their facilities in China, and Suffern, New York. This increase in production capacity ensured that supplies of Coartem met demand which enabled Novartis to further decrease the price of Coartem.
Novartis and its collaborators poured substantial resources into boosting production at their Chinese and Suffern, New York facilities. This enhancement in production ensured sufficient Coartem supply to meet demand, enabling Novartis to lower the Coartem price even more.